A Convertible Loan Note (CLN) is a short-term debt instrument that converts into equity at a future funding round, usually at a discount or subject to a valuation cap. It allows investors to lend money to a company now, with the expectation that the loan will convert into shares once a priced equity round takes place.
CLNs are commonly used in early-stage and bridge financing where the company needs capital quickly but does not want to set a valuation immediately. They combine the speed of debt with the upside potential of equity.
The CLN meaning combines elements of both debt and equity. To define CLN in practice, investors lend money to a company under agreed terms, and that loan converts into shares when a qualifying funding round occurs.
A clear CLN definition typically includes:
Unlike an Advance Subscription Agreement (ASA), a CLN is legally debt until it converts. This means it usually appears as a liability on the company’s balance sheet, which can influence both investor perception and risk assessment.
The mechanics usually follow this sequence:
If no qualifying round occurs before the maturity date, the CLN may:
This repayment feature is one reason CLNs carry a different risk profile from equity-only instruments.
CLNs usually carry interest, often accruing and converting into shares alongside the principal. This increases the number of shares issued at conversion and therefore affects dilution.
The maturity date sets a deadline for conversion or repayment. If the company has not raised a qualifying round by this date, the note terms dictate what happens next.
The discount reduces the price at which the CLN converts compared to the next round’s share price. For example, a 20% discount means the note converts at 80% of the new round price.
A valuation cap sets a maximum company valuation for conversion purposes. If the next round valuation exceeds the cap, the CLN converts at the capped valuation, protecting the investor from excessive price increases before conversion.
Although both defer valuation, there are structural differences:
For founders seeking SEIS/EIS alignment, structure, and drafting are critical.
CLNs are often used in:
They are generally faster to negotiate than a full-priced equity round and can be familiar to investors who are comfortable with debt-style instruments.
Before issuing a CLN, founders should model:
CLNs can be powerful tools when used strategically, but they require careful drafting and forward planning to avoid unintended consequences.
Undo Capital works with founders to structure Convertible Loan Notes (CLNs) in a way that balances speed of fundraising with long-term cap table clarity. This includes advising on key terms such as interest, maturity dates, discounts and valuation caps, modelling conversion outcomes across different scenarios, and ensuring the instrument aligns with future priced rounds, so bridge capital solves short-term needs without creating unintended dilution or structural complexity later.
A CLN is a debt instrument that converts into equity at a later stage, usually during a future funding round, often including terms like interest, valuation cap, and conversion discount.
A CLN accrues interest and is technically debt until conversion, while an ASA is equity-based and does not require repayment or interest.
Conversion typically occurs during a qualifying funding round or at maturity, depending on agreed terms.
They provide quick access to capital while deferring valuation discussions to a later stage.
Disclosure Notice: This communication is issued by Undo Capital Limited (“Undo Capital”) and is provided strictly for informational purposes only. It contains general information and should not be relied upon as accounting, business, financial, investment, legal, tax, or other professional advice. Undo Capital is not regulated by the Financial Conduct Authority (FCA) and does not provide investment, financial, or tax advice. Our services are designed to assist startups and businesses with company formation, legal agreements, and funding-related documentation. Nothing in this communication constitutes, or should be construed as, a recommendation, offer, or solicitation to purchase or sell any security or financial instrument.
Participation in startups and early-stage enterprises involves significant risk. Such investments may be illiquid, may not generate dividends, may be subject to dilution, and may result in the total loss of invested capital. Any decisions or actions that may affect your business or personal interests should be taken only after seeking advice from suitably qualified professional advisors, and should form part of a balanced and diversified portfolio. This communication may contain links to third-party websites. The inclusion of such links does not imply endorsement, approval, investigation, or verification by Undo Capital. We accept no responsibility or liability for the content, accuracy, or use of information contained on any third-party websites.